---
hide:
 - navigation
---
<!DOCTYPE html>
#
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2024-08-09 14:28:16 UTC</i>
  </p>
  
  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <p>
  <h3 data-intro='Recommendations for the article'>
    Recommendations for the article <i>Spatial epitope barcoding reveals subclonal tumor patch behaviors</i>
  </h3>
  <table id="table1" class="display wrap" style="width:100%">
  <thead>
    <tr>
        <th data-intro='Click to view the abstract (if available)'>Abstract</th>
        <th>Title</th>
        <th>Authors</th>
        <th>Publication Date</th>
        <th>Journal/ Conference</th>
        <th>Citation count</th>
        <th data-intro='Highest h-index among the authors'>Highest h-index</th>
    </tr>
  </thead>
  <tbody>
    
        <tr id="Spatial and genomic heterogeneity of tumors is the key for cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their high-resolution localization by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb6a2790cf1b3765aa1bb21c208228815ba2cf26" target='_blank'>Tumoroscope: a probabilistic model for mapping cancer clones in tumor tissues</a></td>
          <td>
            Shadi Darvish Shafighi, Agnieszka Geras, Barbara Jurzysta, Alireza Sahaf Naeini, Igor Filipiuk, Łukasz Rączkowski, Hosein Toosi, Łukasz Koperski, K. Thrane, Camilla Engblom, Jeff E. Mold, Xinsong Chen, J. Hartman, D. Nowis, A. Carbone, J. Lagergren, E. Szczurek
          </td>
          <td>2022-09-23</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>41</td>
        </tr>
    
        <tr id="ABSTRACT We have devised a barcoding strategy to recapitulate cancer evolution through the emergence of subclonal mutations of interest, whose effects can be monitored in a dynamic manner. This approach can be easily adapted for a variety of applications, including combined modeling of multiple mechanisms of drug resistance or repair of oncogenic driver mutations in addicted cancer cells.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71a0b178ffc3b6487e5795be58c139e8c681d562" target='_blank'>Modeling intratumor heterogeneity through CRISPR-barcodes</a></td>
          <td>
            A. Guernet, S. Aaronson, Y. Anouar, L. Grumolato
          </td>
          <td>2016-09-06</td>
          <td>Molecular & Cellular Oncology</td>
          <td>4</td>
          <td>110</td>
        </tr>
    
        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e00764ef398651a1802a4a862aa98e22aba39a33" target='_blank'>The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.</a></td>
          <td>
            O. Rozenblatt-Rosen, A. Regev, Philipp Oberdoerffer, T. Nawy, A. Hupalowska, Jennifer E. Rood, Orr Ashenberg, E. Cerami, R. Coffey, E. Demir, L. Ding, E. Esplin, J. Ford, Jeremy Goecks, Sharmistha Ghosh, J. Gray, J. Guinney, S. Hanlon, Shannon K Hughes, E. Hwang, C. Iacobuzio-Donahue, Judit Jané-Valbuena, B. Johnson, K. Lau, T. Lively, S. Mazzilli, D. Pe’er, S. Santagata, A. Shalek, D. Schapiro, M. Snyder, P. Sorger, A. Spira, S. Srivastava, Kai Tan, Robert West, Elizabeth H. Williams, D. Aberle, S. Achilefu, F. Ademuyiwa, Andrew C. Adey, R. Aft, Rachana Agarwal, Ruben A. Aguilar, Fatemeh Alikarami, V. Allaj, Christopher L Amos, R. Anders, Michael Angelo, K. Anton, J. Aster, O. Babur, Amir Bahmani, Akshay Balsubramani, D. Barrett, J. Beane, D. Bender, K. Bernt, L. Berry, C. Betts, Julie A. Bletz, Katie E. Blise, A. Boire, G. Boland, A. Borowsky, K. Bosse, M. Bott, E. Boyden, James B. Brooks, R. Bueno, Erik A. Burlingame, Q. Cai, Joshua D. Campbell, Wagma Caravan, H. Chaib, J. Chan, Y. Chang, D. Chatterjee, O. Chaudhary, Alyce A. Chen, Bob Chen, Changya Chen, Chia-Hui Chen, F. Chen, Yu-An Chen, M. Chheda, K. Chin, R. Chiu, Shih-Kai Chu, R. Chuaqui, Jaeyoung Chun, Luis H. Cisneros, G. Colditz, K. Cole, Natalie B Collins, K. Contrepois, L. Coussens, A. Creason, D. Crichton, C. Curtis, Tanja Davidsen, S. Davies, I. Bruijn, L. Dellostritto, A. Marzo, D. DeNardo, D. Diep, S. Diskin, Xengie Doan, Julia L. Drewes, Stephen Dubinett, Michael Dyer, J. Egger, Jennifer Eng, Barbara Engelhardt, Graham S. Erwin, L. Esserman, Alex S. Felmeister, H. Feiler, R. Fields, S. Fisher, K. Flaherty, Jennifer Flournoy, A. Fortunato, Allison Frangieh, Jennifer Frye, R. Fulton, Danielle Galipeau, Siting Gan, Jianjiong Gao, Long Gao, Peng Gao, Vianne R. Gao, Timothy A. Geiger, A. George, G. Getz, M. Giannakis, David L. Gibbs, W. Gillanders, S. Goedegebuure, A. Gould, K. Gowers, W. Greenleaf, Jeremy Gresham, Jennifer L. Guerriero, T. Guha, A. Guimaraes, D. Gutman, N. Hacohen, S. Hanlon, C. R. Hansen, O. Harismendy, Kathleen A Harris, A. Hata, Akimasa Hayashi, Cody N. Heiser, K. Helvie, J. Herndon, Gilliam Hirst, F. Hodi, T. Hollmann, Aaron M. Horning, J. Hsieh, Shannon K Hughes, W. J. Huh, S. Hunger, S. Hwang, H. Ijaz, B. Izar, C. Jacobson, S. Janes, R. Jayasinghe, Lihua Jiang, Brett E. Johnson, Bruce Johnson, T. Ju, H. Kadara, K. Kaestner, J. Kagan, L. Kalinke, R. Keith, Aziz Khan, W. Kibbe, A. Kim, E. Kim, Junhyong Kim, A. Kolodzie, Mateusz Kopytra, Eran Kotler, Robert Krueger, K. Krysan, A. Kundaje, U. Ladabaum, B. Lake, Huy Lam, Rozelle Laquindanum, Ashley M. Laughney, Hayan Lee, M. Lenburg, Carin Leonard, I. Leshchiner, Rochelle Levy, Jerry Li, C. Lian, K. Lim, Jia-Ren Lin, Yiyun Lin, Qi Liu, Ruiyang Liu, William J. R. Longabaugh, T. Longacre, Cynthia X. Ma, M. C. Macedonia, T. Madison, C. Maher, A. Maitra, Netta Makinen, Danika Makowski, C. Maley, Z. Maliga, D. Mallo, J. Maris, Nicholas O. Markham, J. Marks, Daniel Martinez, R. J. Mashl, Ignas Masilionais, Jennifer L. Mason, J. Massagué, P. Massion, M. Mattar, R. Mazurchuk, L. Mazutis, Eliot T. McKinley, Joshua F. McMichael, Daniel Merrick, M. Meyerson, J. Miessner, G. Mills, M. Mills, Suman B Mondal, Motomi Mori, Y. Mori, Elizabeth Moses, Y. Mossé, J. Muhlich, G. Murphy, N. Navin, M. Nederlof, R. Ness, Stephanie A. Nevins, Milen Nikolov, A. Nirmal, G. Nolan, Edward Novikov, Brendan L O'Connell, M. Offin, S. Oh, Anastasiya Olson, A. Ooms, Miguel Ossandon, K. Owzar, Swapnil Parmar, Tasleema Patel, G. Patti, I. Pe’er, Tao Peng, Daniel Persson, Marvin Petty, Hanspeter Pfister, K. Polyak, K. Pourfarhangi, Sidharth V. Puram, Q. Qiu, Á. Quintanal-Villalonga, A. Raj, Marisol Ramirez-Solano, R. Rashid, Ashley N. Reeb, M. Reid, A. Resnick, Sheila M. Reynolds, J. Riesterer, S. Rodig, Joseph T. Roland, Sonia M. Rosenfield, Asaf Rotem, Sudipta Roy, C. Rudin, M. Ryser, Mariarita Santi-Vicini, Kazuhito Sato, D. Schrag, N. Schultz, C. Sears, R. Sears, S. Sen, T. Sen, A. Shalek, Jeff Sheng, Quanhu Sheng, K. Shoghi, M. Shrubsole, Y. Shyr, A. Sibley, Kiara Siex, A. Simmons, D. Singer, Shamilene Sivagnanam, M. Slyper, Artem Sokolov, Sheng-Kwei Song, Austin N. Southard-Smith, A. Spira, J. Stein, P. Storm, E. Stover, Siri H. Strand, Timothy Su, D. Sudar, Ryan Sullivan, Lea F. Surrey, M. Suvà, Nadezhda V. Terekhanova, Luke Ternes, Lisa Thammavong, Guillaume Thibault, G. Thomas, V. Thorsson, E. Todres, L. Tran, Madison A Tyler, Yasin Uzun, A. Vachani, E. Allen, S. Vandekar, D. Veis, S. Vigneau, A. Vossough, A. Waanders, N. Wagle, Liang-Bo Wang, M. Wendl, Robert West, Chi-Yun Wu, Hao Wu, Hung-Yi Wu, Matthew A. Wyczalkowski, Yubin Xie, Xiaolu Yang, C. Yapp, Wenbao Yu, Yinyin Yuan, Dadong Zhang, Kun Zhang, Mianlei Zhang, Nancy R. Zhang, Yantian Zhang, Yanyan Zhao, D. Zhou, Zilu Zhou, Houxiang Zhu, Qin Zhu, Xiangzhu Zhu, Yuankun Zhu, X. Zhuang
          </td>
          <td>2020-04-16</td>
          <td>Cell</td>
          <td>319</td>
          <td>224</td>
        </tr>
    
        <tr id="Introduction Cancer is an evolutionary process in which the stepwise accumulation of genetic alterations is shaped by Darwinian selection. As a result, each tumour is composed of a complex mixture of clonal cell subpopulations containing a partially overlapping, but distinct, pattern of driver and passenger mutations. Such intratumor heterogeneity has dramatic consequences, not only for cancer progression and metastatic spread, but also for resistance to therapy. We recently devised a novel approach based on CRISPR/Cas9 technology to recapitulate and trace the emergence of a new mutation in a subset of cancer cells, thus enabling functional studies on a gene of interest in a context that mimics intratumor heterogeneity. Material and methods We used CRISPR/Cas9 technology to insert a potentially functional modification in the sequence of a gene of interest, coupled to a series of silent point mutations, serving as a genetic label for cell tracing. Because of HDR low efficiency, the modified allele can be introduced only in a small fraction of cells, thus mimicking the emergence of new mutant clones within a cancer mass population. In parallel, a second barcode, consisting of different silent mutations, was used as an internal control for possible CRISPR off-target cleavage. After exposing the cells to a given selective condition, the effects of the mutation of interest can be analysed by measuring the proportion of each barcode in genomic DNA by real-time quantitative PCR or deep sequencing. Results and discussions We used this CRISPR-barcoding strategy to model different mechanisms of non-small-cell lung cancer resistance to EGFR inhibitors, and we established a multiplex system to evaluate the efficacy of combined drug therapies aimed at preventing or delaying the emergence of resistant cells. Through a similar approach, we assessed the effects of repairing oncogenic driver mutations in addicted cancer cells directly at the genome level. Finally, we used a highly complex set of CRISPR-barcodes to trace intratumor heterogeneity, as a convenient alternative strategy to lentiviral barcode libraries. Conclusion CRISPR-barcoding is a fast and highly flexible means to investigate the effects of different kinds of genomic modifications in a broad range of functional assays.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e82c5aced4133b10bb0a553cfe7355fd594d0e92" target='_blank'>Po-327 Modelling intratumor heterogeneity through CRISPR-barcodes</a></td>
          <td>
            Nad Marzouka, P. Eriksson, David Lindgren, Fredrik Liedberg, C. Bernardo, G. Sjödahl, Håkan Axelson, Mattias Höglund
          </td>
          <td>2018-06-01</td>
          <td>ESMO Open</td>
          <td>0</td>
          <td>34</td>
        </tr>
    
        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9a95db304a3a2602d501dd51f061db80be330a3c" target='_blank'>Spatial characterization of single tumor cells by proteomics</a></td>
          <td>
            
          </td>
          <td>2022-05-19</td>
          <td>Nature Biotechnology</td>
          <td>1</td>
          <td>0</td>
        </tr>
    
        <tr id="Tumors may contain billions of cells including distinct malignant clones and nonmalignant cell types. Clarifying the evolutionary histories, prevalence, and defining molecular features of these cells is essential for improving clinical outcomes, since intratumoral heterogeneity provides fuel for acquired resistance to targeted therapies. Here we present a statistically motivated strategy for deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial tumor sections (MOMA). By combining deep sampling of IDH-mutant astrocytomas with integrative analysis of single-nucleotide variants, copy-number variants, and gene expression, we reconstruct and validate the phylogenies, spatial distributions, and transcriptional profiles of distinct malignant clones. By genotyping nuclei analyzed by single-nucleus RNA-seq for truncal mutations, we further show that commonly used algorithms for identifying cancer cells from single-cell transcriptomes may be inaccurate. We also demonstrate that correlating gene expression with tumor purity in bulk samples can reveal optimal markers of malignant cells and use this approach to identify a core set of genes that is consistently expressed by astrocytoma truncal clones, including AKR1C3, whose expression is associated with poor outcomes in several types of cancer. In summary, MOMA provides a robust and flexible strategy for precisely deconstructing intratumoral heterogeneity and clarifying the core molecular properties of distinct cellular populations in solid tumors.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a42d55360375575f6b72f5d2adcce6dce183893" target='_blank'>Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections</a></td>
          <td>
            Patrick G. Schupp, Samuel J. Shelton, Daniel J. Brody, Rebecca Eliscu, Brett E. Johnson, T. Mazor, Kevin W. Kelley, M. Potts, M. W. McDermott, E. Huang, D. Lim, R. Pieper, Mitchel S. Berger, J. Costello, J. Phillips, Michael C. Oldham
          </td>
          <td>2023-08-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>68</td>
        </tr>
    
        <tr id="Simple Summary Tumors contain cancerous cells with different mutations and different types of non-cancerous cells. It is important to understand the molecular properties of these cells in order to develop effective treatments for cancers. We describe a new strategy for studying tumor heterogeneity and apply it to human astrocytomas, a type of brain tumor. By slicing astrocytomas into a large number of serial sections and analyzing patterns of mutation frequencies, we reconstruct the evolutionary history of cancer cell mutations in each tumor. By comparing these patterns to gene activity measured in the same sections, we identify molecular features that optimally distinguish different types of cancerous and non-cancerous cells and validate these with different techniques, including analysis of individual nuclei. By integrating analyses of multiple molecular species at multiple scales, our strategy provides a powerful approach for precisely deconstructing intratumoral heterogeneity. Abstract Tumors may contain billions of cells, including distinct malignant clones and nonmalignant cell types. Clarifying the evolutionary histories, prevalence, and defining molecular features of these cells is essential for improving clinical outcomes, since intratumoral heterogeneity provides fuel for acquired resistance to targeted therapies. Here we present a statistically motivated strategy for deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial tumor sections (MOMA). By combining deep sampling of IDH-mutant astrocytomas with integrative analysis of single-nucleotide variants, copy-number variants, and gene expression, we reconstruct and validate the phylogenies, spatial distributions, and transcriptional profiles of distinct malignant clones. By genotyping nuclei analyzed by single-nucleus RNA-seq for truncal mutations, we further show that commonly used algorithms for identifying cancer cells from single-cell transcriptomes may be inaccurate. We also demonstrate that correlating gene expression with tumor purity in bulk samples can reveal optimal markers of malignant cells and use this approach to identify a core set of genes that are consistently expressed by astrocytoma truncal clones, including AKR1C3, whose expression is associated with poor outcomes in several types of cancer. In summary, MOMA provides a robust and flexible strategy for precisely deconstructing intratumoral heterogeneity and clarifying the core molecular properties of distinct cellular populations in solid tumors.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/19f10a20bb87365187cbad7becc484185a46f9af" target='_blank'>Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections</a></td>
          <td>
            Patrick G. Schupp, Samuel J. Shelton, Daniel J. Brody, Rebecca Eliscu, Brett E Johnson, T. Mazor, Kevin W. Kelley, Matthew B. Potts, Michael W. McDermott, Eric J. Huang, Daniel A. Lim, Russell O. Pieper, Mitchell S. Berger, Joseph F. Costello, Joanna J Phillips, Michael C. Oldham
          </td>
          <td>2024-07-01</td>
          <td>Cancers</td>
          <td>0</td>
          <td>24</td>
        </tr>
    
        <tr id="Many malignant cancers like glioblastoma are highly adaptive diseases that dynamically change their regional biology to survive and thrive under diverse microenvironmental and therapeutic pressures. While the concept of intra‐tumoral heterogeneity has become a major paradigm in cancer research and care, systematic approaches to assess and document bio‐variation in cancer are still in their infancy. Here we discuss existing approaches and challenges to documenting intra‐tumoral heterogeneity and emerging computational approaches that leverage artificial intelligence to begin to overcome these limitations. We propose how these emerging techniques can be coupled with a diversity of molecular tools to address intra‐tumoral heterogeneity more systematically in research and in practice, especially across larger specimens and longitudinal analyses. Systematic documentation and characterization of heterogeneity across entire tumor specimens and their longitudinal evolution has the potential to improve our understanding and treatment of cancer.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2cfa7353f1105e92b3c276a5b736d18e45c4361e" target='_blank'>Standardizing analysis of intra‐tumoral heterogeneity with computational pathology</a></td>
          <td>
            Ameesha Paliwal, K. Faust, Azhar Alshoumer, P. Diamandis
          </td>
          <td>2023-04-17</td>
          <td>Genes</td>
          <td>1</td>
          <td>25</td>
        </tr>
    
        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f2bf0e028aa7d79087ee8ee1bf9c6a6ea3815c4" target='_blank'>Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance</a></td>
          <td>
            H. Alkhatib, A. Rubinstein, S. Vasudevan, E. Flashner-Abramson, S. Stefansky, Sangita Roy Chowdhury, S. Oguche, Tamar Peretz-Yablonsky, Avital Granit, Z. Granot, I. Ben-Porath, K. Sheva, Jon Feldman, Noa E. Cohen, A. Meirovitz, N. Kravchenko‐Balasha
          </td>
          <td>2022-10-20</td>
          <td>Genome Medicine</td>
          <td>12</td>
          <td>35</td>
        </tr>
    
  </tbody>
  <tfoot>
    <tr>
        <th>Abstract</th>
        <th>Title</th>
        <th>Authors</th>
        <th>Publication Date</th>
        <th>Journal/Conference</th>
        <th>Citation count</th>
        <th>Highest h-index</th>
    </tr>
  </tfoot>
  </table>
  </p>

</body>

<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: false,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '5%', targets: 0 },
        { width: '25%', targets: 1 },
        { width: '20%', targets: 2 },
        { width: '10%', targets: 3 },
        { width: '20%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  
  var table = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>